11 completed, 4 unknown, 3 recruiting, 2 active not recruiting. 12 Not applicable, 3 Phase 2, 3 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 12 | Completed 5, Active not recruiting 2, Recruiting 2, Unknown 2, Terminated 1 |
| Phase 2 | 3 | Completed 3 |
| Phase 4 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Postgastrectomy Syndromes: new trials by email Literature Review of Postgastrectomy Syndromes trials Research Report on Postgastrectomy Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dumping Syndrome After Esophagectomy Esophagectomy, Dumping Syndrome | Recruiting | Samsung Medical Center | 30 | 2026-06-15 | 2026-05-26 | |
| Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome Can i3 Continuous Glucose Monitoring System - Dumping Syndrome, Post-bariatric Hypoglycemia | Not applicable | Recruiting | Kaiser Clinic and Hospital | 60 | 2025-10-15 | 2026-02-27 |
| Feasibility Study of Middle Segmental Gastrectomy (MSG) for Gastric Cancer. Totally Laparoscopic Middle Segmental Gastrectomy (TLMSG) - Gastric Cancer, Gastric Adenocarcinoma | Not applicable | Active not recruiting | National Cancer Center, Korea | 78 | 2025-06-15 | 2026-10-27 |
| Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in Adults With Obesity Sleeve Gastrectomy, Sleeve Gastrectomy with Transit Bipartition - Obesity, Morbid Obesity | Not applicable | Active not recruiting | Mina Kamal Gergis Erian | 200 | 2024-04-06 | 2025-12-04 |
| Mandatory Hiatoplasty in Sleeve Gastrectomy for Gastro-Esophageal Reflux Disease Postgastrectomy Syndromes, Gastroesophageal Reflux | Unknown | Instituto Mexicano del Seguro Social | 275 | 2024-03-01 | 2024-03-18 | |
| Dumping Syndrome and Esophageal Atresia Glycemic Holter, gastric emptying scintigraphy, Holter ECG - Oesophageal Atresia, Dumping Syndrome | Not applicable | Recruiting | University Hospital, Lille | 15 | 2024-02-23 | 2025-12-23 |
| Effects of Active Release Technique (ART) on Pectoralis Minor Tightness in Post Mastectomy Women. active release group, active control group - Postgastrectomy Syndrome | Not applicable | Completed | Riphah International University | 60 | 2022-08-10 | 2023-01-25 |
| Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass Empagliflozin 25 MG, Placebo - Dumping Syndrome, Hypoglycemia, Reactive | Phase 4 | Completed | Insel Gruppe AG, University Hospital Bern | 22 | 2021-12-01 | 2023-03-14 |
| Fat Supplementation on Dumping Syndrome Related Symptoms After Gastric Surgery Dietary Supplement: Resource Energy, Dietary Supplement: Calogen - Dumping Syndrome, Gastric Surgery | Not applicable | Unknown | Larissa University Hospital | 30 | 2021-09-28 | 2023-03-22 |
| MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS) MAGUS - Diverticulum, Esophageal, Post Gastric Surgery Syndrome | Not applicable | Completed | Erasme University Hospital | 16 | 2020-02-19 | 2021-12-08 |
| Fat Supplementation on Dumping Syndrome Associated Symptoms Calogen, Resource Energy - Dumping Syndrome | Not applicable | Unknown | Technological Educational Institute of Thessaly | 25 | 2017-09-12 | 2022-11-15 |
| Gastrectomy, Eating Behaviour and GLP-1 Exendin 9-39, Placebo - Gastric Cancer, Dumping Syndrome | Not applicable | Completed | Cambridge University Hospitals NHS Foundation Trust | 5 | 2017-08-10 | 2019-08-29 |
| Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity Dietary and nutritional recommendations conducted by a nurse - Dumping Syndrome | Not applicable | Completed | University Hospital, Lille | 135 | 2017-03-02 | 2021-04-21 |
| Metabolic Consequences of Gastrointestinal Surgery Somatostatin, Rifaximin - Gastrectomy, Oesophagectomy | Not applicable | Terminated | Cambridge University Hospitals NHS Foundation Trust | 81 | 2017-01-01 | 2019-04-02 |
| Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery Octreotide Acetate, Saline Solution, Paracetamol - Esophageal Cancer, Nutrition Disorders | Completed | St. James's Hospital, Ireland | 40 | 2016-07-01 | 2021-08-16 | |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Pasireotide, Cabergoline, Pasireotide LAR - Cushing's Disease, Acromegaly | Phase 4 | Completed | RECORDATI GROUP | 337 | 2013-06-10 | 2024-10-01 |
| Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome SOM230 - Dumping Syndrome | Phase 2 | Completed | Novartis Pharmaceuticals | 43 | 2013-01-08 | 2017-05-10 |
| Dumping Syndrome After Operation of Esophageal Atresia Type III Oral Glucose - Oesophageal Atresia, Dumping Syndrome | Not applicable | Completed | University Hospital, Lille | 42 | 2011-06-14 | 2026-05-14 |
| Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome Pasireotide, Placebo - Postoperative Dumping Syndrome | Phase 2 | Completed | Universitaire Ziekenhuizen KU Leuven | 9 | 2008-09-01 | 2013-07-10 |
| SOMATULINE Autogel 90 mg IN DUMPING SYNDROME Lanreotide 90 mg slow release formulation, Placebo - Dumping Syndrome | Phase 2 | Completed | Universitaire Ziekenhuizen KU Leuven | 24 | 2008-04-01 | 2023-01-27 |
Showing 20 of 22. Sign in to see all of them.
Dumping Syndrome (19) · Hypoglycemia (5) · Stomach Neoplasms (3) · Esophageal Atresia (2) · Insulin Resistance (2) · Obesity (2) · Acromegaly (1) · Breast Neoplasms (1) · Diverticulum, Esophageal (1) · Esophageal Motility Disorders (1) · Esophageal Neoplasms (1) · Feeding and Eating Disorders (1) · Gastroesophageal Reflux (1) · Gastroparesis (1)
Digestive System Diseases (22) · Gastrointestinal Diseases (22) · Pathologic Processes (22) · Pathological Conditions, Signs and Symptoms (22) · Stomach Diseases (22) · Postoperative Complications (21) · Nutritional and Metabolic Diseases (10) · Glucose Metabolism Disorders (8) · Metabolic Diseases (8) · Neoplasms by Site (6) · Neoplasms (5) · Digestive System Neoplasms (4) · Esophageal Diseases (4) · Gastrointestinal Neoplasms (4)
pasireotide (3) · lanreotide (2) · Acetaminophen (1) · Cabergoline (1) · Delayed-Action Preparations (1) · Diet (1) · Electrocardiography, Ambulatory (1) · Energy-Generating Resources (1) · Gastric Bypass (1) · Gastroenterostomy (1) · Glucose (1) · Octreotide (1) · Rifaximin (1) · Saline Solution (1) · Somatostatin (1)
University Hospital, Lille (3) · Cambridge University Hospitals NHS Foundation Trust (2) · Universitaire Ziekenhuizen KU Leuven (2) · Erasme University Hospital (1) · Insel Gruppe AG, University Hospital Bern (1) · Instituto Mexicano del Seguro Social (1) · Kaiser Clinic and Hospital (1) · Larissa University Hospital (1) · Mina Kamal Gergis Erian (1) · National Cancer Center, Korea (1) · Novartis Pharmaceuticals (1) · RECORDATI GROUP (1) · Radboud University Medical Center (1) · Riphah International University (1) · Samsung Medical Center (1)
Belgium (5) · France (5) · South Korea (4) · Greece (3) · Netherlands (3) · Brazil (2) · Germany (2) · Mexico (2) · Switzerland (2) · United Kingdom (2) · United States (2) · Argentina (1) · Bulgaria (1) · Canada (1) · Egypt (1)
Aisha Razzaq, MSPT-OMPT (1) · Carel W le Roux, FRCP FRCPath PhD (1) · Fiona M Gribble, PhD (1) · Geoffrey P Roberts, MA BM BCh (1) · Geoffrey Roberts, MA BM BCh (1) · Helmut Heribert, MD, PhD (1) · Isaac Esparza Estrada, MD, PhD (1) · Jan Tack, M.D., Ph.D. (1) · John V Reynolds, MD FRCS (1) · Laurent Michaud, MD (1)
PMID 11527163, PMID 11743518, PMID 12948306, PMID 17638154, PMID 20385264, PMID 29548882, PMID 30726726, PMID 30733330, PMID 32443041, PMID 34282579, PMID 34979115, PMID 36123073, PMID 37093196, PMID 8890072
2008 (2)